- Wells Fargo COO Scott Powell to become chief risk officer as Derek Flowers retires
- H.B. Fuller Q3 net income beats estimates on pricing actions, restructuring savings
- Tessenderlo Group buys 30,319,166 FMC shares for USD 403 million, takes 20% stake
- American Express to webcast third-quarter earnings call
- Talos Energy appoints retired Air Force Maj. Gen. Barbara Faulkenberry to board
- AZZ schedules fiscal Q2 earnings call, sets results release timing
- ViaSat CFO Garrett L. Chase sells USD 308,596.93 in common shares
- POC Precision Optics schedules conference call on Q4, FY2026 results
- Sarepta settles REGENXBIO, UPenn patent litigation for USD 39 million
- Piper Sandler director Wendy Lee Schoppert files initial beneficial ownership statement
- GenFlat director Jonathan Michael Hoch files initial beneficial ownership statement
- H.B. Fuller Fiscal Q3 Adjusted Earnings, Revenue Rise
- Joby Aviation Chief Policy Officer Gregory Bowles disposes of 6,138 common shares for $38,976.3
- AGF says North American equities shrug off Canada-US trade war impact
- Core Scientific Chief Legal and Administrative Officer Todd DuChene sells USD 183,746 of common shares
- Ready Capital amends note indenture to loosen leverage cap and reset net asset value floor
- Exclusive Report - Sources say Hellman & Friedman is exploring the sale of Applied Systems at a price of up to $10 billion.
- Northern Trust to Webcast Q3 Earnings Conference Call
- BWX Technologies: Fitch Cited Strong Position in Providing Critical Nuclear Reactor Components and Fuel for U.S. Naval Propulsion and Other Strategic Government Programs >BWXT
- BWX Technologies: Fitch Cited Position Backed by Specialized Licenses, Intellectual Property and Ability to Meet Stringent Regulatory Requirements >BWXT
- BWX Technologies: Fitch Also Cited Multi-Yr Rev Visibility and Cash Flow Stability Supported by Robust Backlog >BWXT
- --First United Raises Quarterly Dividend to $0.28 a Share From $0.26, Payable Nov. 2 to Holders of Record Oct. 19
- Hemostemix files for price protection on C$1 million private placement third tranche units offering
- Virtus AllianzGI Artificial Intelligence & Technology Opportunities Fund lifts monthly distribution to $0.21 per share from $0.18
- Flotek secures USD 120 million senior secured term loan led by Elda River Capital Management
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- BWX Technologies: Inaugural Investment Grade Credit Rating of BBB With a Stable Outlook From Fitch Ratings >BWXT
- BWX Technologies: Receives BBB Investment Grade Rating From Fitch Ratings
- Canadian Solar Unit Recurrent Energy Receives ISO 14001 Certification
- Intapp CEO John T. Hall disposes of 3,000 common shares for USD 110,220
- HB Fuller Backs FY26 View for Cash Flow From Ops, Ex-Impact of AMS-related Items, of $300 M to $325 M >FUL
- HB Fuller Sees FY26 Adj EPS $4.70-Adj EPS $4.85 >FUL
- CBL & Associates Properties Insider Sold Shares Worth $366,653, According to a Recent SEC Filing
- Galaxy Digital names Dritan Muneka principal accounting officer, effective Sept. 30
- AerCap prices USD 1.5 billion senior notes offering
- AllianceBernstein National Municipal Income Fund adopts managed distribution policy, sets monthly payout at $0.067 a share
- Evofem contracts second manufacturer for Phexxi contraceptive gel
- HB Fuller FY26 Revenue Is Still Expected to Be Up Mid-Single Digits >FUL
- SOS Ltd closes private placement with non-U.S. investors
- Arcturus Therapeutics: To Acquire myNEO, an AI Discovery Co, to Improve mRNA Design Quality, Accelerate Innovation, Enhance Target Identification Capability >ARCT
- HB Fuller Sees FY26 Pricing Up Mid-Single Digits and Volume Down Low-Single Digits >FUL
- Torrent Capital estimates August 2026 NAV at $31.2 million, or $0.82 a share, up from $30.6 million in July
- Mobile Infrastructure extends Harvest Small Cap credit agreement maturity to Dec. 31, 2026
- SonicStrategy director Spencer MacLean resigns from board
- Evommune to present Phase 2a EVO301 atopic dermatitis data at EADV 2026 late-breaker session
- AllianceBernstein National Municipal Income Fund sets monthly distribution at $0.067 a share under managed payout policy
- MariMed announces special shareholder meeting on reverse stock split proposal
- H.B. Fuller FY26 Q3 net income rises 17.9% to $79.18 million; net revenue climbs 5.2% to $938.18 million
- BWX Technologies receives inaugural BBB investment-grade rating from Fitch
- Nextdoor Chief Accounting Officer Antoinette How disposes of 40,000 shares worth USD 105,020
- Regenxbio settles Sarepta patent litigation over Elevidys for USD 39 million
- FutureFuel holds annual shareholder meeting
- Medpace CEO August J. Troendle disposes of USD 44.42 million in common shares
- Eva Live issues unregistered warrant for 275,000 shares at USD 0.01 exercise price
- Casella Waste Systems makes 2026 sustainability report available online
- Mineralys says Transform-HTN extension data on lorundrostat set for late-breaking AHA 2026 presentation
- BRIEF-H.B. Fuller Q3 Adjusted EPS USD 1.52 Vs. IBES Estimate USD 1.47
- Saratoga Investment prices additional USD 20.08 million offering of 8% unsecured notes due 2031
- BRIEF-Stitch Fix Q4 EPS USD -0.02
- Grid Dynamics co-hosts Physical AI Summit with Nvidia, EAIGG and BGV
- --ATN International Keeps Quarterly Dividend at $0.29 per Share, Payable Oct. 9 to Holders of Record Oct. 3
- -- Earnings Flash (FUL) H.B. Fuller Company Posts Q3 Adjusted EPS $1.52 per Share, vs. FactSet Est of $1.47
- -- Earnings Flash (FUL) H.B. Fuller Company Reports Q3 Revenue $938.2M, vs. FactSet Est of $945.6M
- Arcturus Therapeutics: ARCT-810 Generally Safe and Well Tolerated, Demonstrating Encouraging Activity Across Key Urea Cycle Biomarkers in Ongoing Phase 2 Study >ARCT
- Stitch Fix Sees FY27 Rev $1.31B-$1.36B >SFIX
- Stitch Fix Sees 1Q Rev $323M-$328M >SFIX
- Fast Track Entertainment says Nasdaq files Form 25 to delist shares, trading stays on OTC Markets
- Virtus AllianzGI Diversified Income & Convertible Fund lifts monthly distribution to USD 0.215 a share
- Revvity CFO Maxwell Krakowiak sells 1,631 shares worth $235,525.43
- Zscaler to host investor day webcast
- SRX Global CEO Cunningham, EMJX platform head Jackson to present at Webull fintech investor webinar
- Hanover Insurance to release Q3 results after market close, host webcast on earnings discussion
- HB Fuller 3Q EPS $1.44 >FUL
- Stitch Fix 4Q Loss $2.07M >SFIX
- HB Fuller 3Q Adj EPS $1.52 >FUL
- Stitch Fix 4Q Rev $324.4M >SFIX
- --Stitch Fix Reports 2.277 Million Active Clients in Q4 vs FactSet Analyst Consensus of 2.293 Million
- MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG
- MiMedx Group: Court Vacates FDA Determinations That Axiofill Isn't Minimally Manipulated, Should Be Classified as Biological Product
- Longeveron says ELPIS II Phase 2b trial of laromestrocel in HLHS misses primary endpoint at 12 months
- CBL Properties EVP Financial Planning & Analysis Joseph Khalili sells 6,763 shares for USD 366,150.67
- Stitch Fix FY26 net loss narrows to $12.6 million; revenue rises 6.4% to $1.35 billion
- Top Wealth Group chairman Kim Kwan Kings Wong resigns on health grounds
- Phio Pharmaceuticals CEO Robert J. Bitterman acquires $2,057.80 in common shares
- Arcturus reports interim Phase 2 data for ARCT-810 in OTC deficiency trial
- Five Below names ex-Ulta CFO Scott Settersten to board, audit committee
- Gossamer Bio submits FDA NDA for seralutinib in pulmonary arterial hypertension
- Arcturus says ARCT-810 Phase 2 interim data in OTC deficiency show safety, biomarker improvement
- Zymeworks completes acquisition of Theravance Biopharma
- Innocan Pharma closes C$ 462,477 private placement of 247,314 units at C$ 1.87 each
- Stoke Therapeutics names Solid Biosciences CEO Bo Cumbo to board
- IM Cannabis regains Nasdaq compliance with $1 minimum bid price rule
- US judge vacates FDA ruling on MiMedx AXIOFILL regulatory classification
- EQT Private Equity posts August 31 transactional NAV of $1.1 million, $30.55 per share for Class I
- Zymeworks Completes Acquisition Of Theravance Biopharma >ZYME
- Five Below Appoints Scott Settersten to Its Bd of Directors
- Five Below's Board Increased to Ten Directors >FIVE
